Inozyme Pharma Inc. (INZY)

NASDAQ: INZY · Real-Time Price · USD

1.64

0.43 (35.54%)

At close: May 02, 2025, 3:59 PM

1.63

-0.31%

After-hours: May 02, 2025, 05:58 PM EDT

Inozyme Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-102.02M	-71.17M	-67.06M	-56.62M	-56.42M	-19.72M	-6.96M
Depreciation & Amortization	742K	833K	744K	674K	217K	83K	26K
Stock-Based Compensation	7.95M	7.04M	7.67M	7.16M	2.31M	301K	444K
Other Working Capital	3.35M	-1.7M	1.86M	760K	-2.21M	684K	629K
Other Non-Cash Items	-3.28M	-4.29M	-1.13M	378K	18.04M	-71K	-4.37M
Deferred Income Tax	n/a	n/a	n/a	170K	n/a	n/a	n/a
Change in Working Capital	4.71M	-3.08M	2.01M	85K	-111K	601K	1.43M
Operating Cash Flow	-91.91M	-70.67M	-57.76M	-48.15M	-35.97M	-18.81M	-9.44M
Capital Expenditures	-62K	-298K	-410K	-397K	-568K	-139K	-259K
Cash Acquisitions	n/a	n/a	4.99K	-43.19K	116.61K	8.25K	n/a
Purchase of Investments	-155.05M	-269.33M	-151.99M	-121.97M	-177.92M	-24.66M	-13.57M
Sales Maturities Of Investments	222.11M	215.98M	147M	165.16M	61.31M	16.41M	22.83M
Other Investing Acitivies	n/a	n/a	-4.99K	43.19K	-116.61K	-8.25K	9.27M
Investing Cash Flow	67M	-53.65M	-5.4M	42.8M	-117.18M	-8.39M	9.01M
Debt Repayment	n/a	40M	4.05M	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	877K	322K	12.6M	609K	202K	72K	n/a
Financial Cash Flow	11.4M	125.97M	72.79M	609K	149.81M	22.97M	31.95M
Net Cash Flow	-13.51M	1.63M	9.6M	-4.72M	-3.34M	-4.23M	31.51M
Free Cash Flow	-91.97M	-70.97M	-58.17M	-48.55M	-36.54M	-18.95M	-9.7M